Kadmon Corporation, LLC (kadmon)

Oncology Corporate Profile

HQ Location

450 East 29th Street, 5th Floor
New York, NY 10016

Company Description

Kadmon Corporation, LLC, is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of liver diseases, and is pioneering novel medicines in areas of serious disease, including oncology, immunology and infectious, neurodegenerative and ophthalmic diseases. Emphasizing emerging concepts in molecular biology and genomics, Kadmon is developing treatments and treatment combinations that target the metabolomics and signaling pathways associated with disease, with the goal of addressing some of today's most pressing areas of unmet medical need.

Website: http://www.kadmon.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
KD032RAS protein inhibitorNon Small Cell Lung Cancer (NSCLC)II
KD019tyrosine kinase inhibitorNon Small Cell Lung Cancer (NSCLC)II
KD032RAS protein inhibitorPancreatic cancerII
KD019tyrosine kinase inhibitorBreast cancerI
KD032RAS protein inhibitorColorectal cancerI
KD019tyrosine kinase inhibitorProstate cancerI

View additional information on product candidates here »

Source: http://www.kadmon.com

Recent News Headlines

There are no news items to display